In mice fed a Western diet, RDX8940, like liraglutide, improved insulin sensitivity and measures of liver steatosis, in line with the previously reported effects of GLP-1 therapy in animal models of NASH (12, 25, 33). Here, INS is linked to metabolic dysfunction-associated steatohepatitis.